Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.
SERPINA1
TMPRSS2
alpha1‑antitrypsin
lung cancer
prognostic factor
Journal
International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
13
10
2021
accepted:
31
01
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
23
3
2022
Statut:
ppublish
Résumé
Transmembrane serine protease 2 (TMPRSS2) has been intensively investigated during the current Sars‑CoV‑2 pandemic as a virus activating protease. Furthermore,
Identifiants
pubmed: 35211754
doi: 10.3892/ijo.2022.5329
pii: 39
pmc: PMC8878627
doi:
pii:
Substances chimiques
Biomarkers, Tumor
0
Serine Endopeptidases
EC 3.4.21.-
TMPRSS2 protein, human
EC 3.4.21.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Genomics. 1997 Sep 15;44(3):309-20
pubmed: 9325052
J Exp Clin Cancer Res. 2020 Sep 23;39(1):200
pubmed: 32967703
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):451-455
pubmed: 33245471
J Int Med Res. 2013 Jun;41(3):573-83
pubmed: 23613495
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Oncotarget. 2015 Sep 22;6(28):25815-27
pubmed: 26158350
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Biochem J. 2005 Jun 15;388(Pt 3):967-72
pubmed: 15537383
Mol Ther Methods Clin Dev. 2020 May 22;18:1-6
pubmed: 32537478
J Virol. 2019 Mar 5;93(6):
pubmed: 30626688
Mol Endocrinol. 2013 Dec;27(12):2028-40
pubmed: 24109594
Pain. 2015 May;156(5):923-930
pubmed: 25734995
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098
pubmed: 32501810
Am J Cancer Res. 2017 Nov 01;7(11):2257-2274
pubmed: 29218249
Nat Commun. 2021 Jul 1;12(1):4068
pubmed: 34210968
Nat Commun. 2021 Mar 19;12(1):1726
pubmed: 33741941
J Immunol. 2015 Sep 1;195(5):2122-33
pubmed: 26238490
Front Med (Lausanne). 2020 Dec 04;7:619453
pubmed: 33425965
Nat Cancer. 2020 Oct;1(10):946-964
pubmed: 35121872
Breast Cancer Res Treat. 2006 Nov;100(2):229-35
pubmed: 16932852
Cancer Res. 2001 Feb 15;61(4):1686-92
pubmed: 11245484
Am J Pathol. 2011 Sep;179(3):1110-9
pubmed: 21723846
Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):486-503
pubmed: 30321617
J Pathol. 2000 Feb;190(2):150-6
pubmed: 10657012
Pathog Immun. 2021 Apr 26;6(1):55-74
pubmed: 33969249
Clin Cancer Res. 2015 Aug 1;21(15):3529-40
pubmed: 25901080
Proc Natl Acad Sci U S A. 2020 Dec 11;:
pubmed: 33310900
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447
pubmed: 32667668
Cancers (Basel). 2019 Jun 25;11(6):
pubmed: 31242643
Mol Cancer. 2020 Apr 28;19(1):80
pubmed: 32345328
Respir Med. 2011 Aug;105(8):1129-39
pubmed: 21367592
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5322-30
pubmed: 17855650
Cancers (Basel). 2019 Sep 04;11(9):
pubmed: 31487965
Front Pharmacol. 2021 Apr 22;12:625289
pubmed: 33967759